Discovery Lecture

Nobel laureate Jennifer Doudna, winner of the 2020 Vanderbilt Prize in Biomedical Science, will deliver the next web-based Discovery Lecture on Thursday, July 22. Doudna is recipient of the 2020 Nobel Prize in Chemistry for the co-development of the revolutionary genome editing technology known as CRISPR-Cas9. Read More

Richard Tsien, PhD, director of the Neuroscience Institute at NYU Langone Medical Center, will deliver the next web-based Discovery Lecture. Read More

David DeMets, PhD, known for his work on statistical methods to monitor interim clinical trial data for early evidence of benefit or harm, will deliver the next web-based Discovery Lecture. Read More

Mukesh Jain, MD, vice dean for Academic Affairs and Medical Sciences and professor of Medicine at Case Western Reserve University, will discuss the discovery of aging-related disease genes and pathways during the next web-based Discovery Lecture. Read More

The human brain consists of perhaps as many as 1,000 trillion synapses, which transmit signals from one nerve cell to another with amazing speed, precision and plasticity. Read More

The spring Flexner Discovery Lecture series wraps up on Thursday, April 26, with a presentation by Terry Orr-Weaver, PhD, professor of Biology at the Massachusetts Institute of Technology. Read More

Brian Kobilka, MD, who received the 2012 Nobel Prize in Chemistry for his studies of G protein-coupled receptors (GPCRs), shared his team’s progress in understanding receptor activation — and how that might guide drug development — at last week’s Flexner Discovery Lecture. Read More

Paul Tang, an expert in health information technology, will deliver the next Flexner Discovery Lecture on Thursday, April 12. Read More

Brian Kobilka, MD, who shared the 2012 Nobel Prize in Chemistry for his studies of G protein-coupled receptors (GPCRs), will deliver the next Flexner Discovery Lecture on April 5. Read More

K. Dane Wittrup, PhD, a pioneer in protein engineering technologies who has helped accelerate development of antibody therapies for cancer, will deliver the next Flexner Discovery Lecture on Thursday, March 22. Read More

James Allison, PhD, whose work led to the development of cancer immunotherapies known as “checkpoint inhibitors,” will deliver the next Flexner Discovery Lecture on Thursday, March 8. Read More

Oregon Health and Sciences University’s Eric Gouaux, PhD, discussed mechanisms of signal transduction and clearance at the chemical synapses of the brain during his recent Flexner Discovery Lecture. Read More

Eric Gouaux, PhD, whose work has helped reveal the molecular mechanisms by which nerve cells communicate, will deliver the next Flexner Discovery Lecture Thursday, Feb. 22. Read More

Bruce Gelb, MD, an expert on congenital heart defects, will deliver the next Flexner Discovery Lecture on Thursday, Feb. 8. Read More

Clinical trials expert Roger Lewis, MD, PhD, right, poses with Vanderbilt’s Yu Shyr, MD, following his recent Discovery Lecture. Lewis is chair of Emergency Medicine at Harbor-UCLA Medical Center in Los Angeles. Read More

Roger Lewis, MD, PhD, a national expert on methods that can improve the flexibility and efficiency of clinical trials, will deliver the next Flexner Discovery Lecture on Thursday, Jan. 4, 2018. Read More

Basic research underway at Vanderbilt University Medical Center is raising hopes that one day it will be possible to reverse memory loss in people with Alzheimer’s disease and stop a major driver of cancer in its tracks. Read More

Sally Wenzel, M.D., a global expert on severe asthma, will deliver the next Flexner Discovery Lecture on Thursday, Nov. 9. Read More

Consuelo Wilkins, M.D., MSCI, and Joshua Denny, M.D., M.S., discussed the potential of precision medicine during their recent Flexner Discovery Lecture. Read More

How epigenetic regulation of gene transcription forms new memories and triggers cancerous growth is the subject of the next Vanderbilt Discovery Lecture on Oct. 26. Read More